ACOG recommends vaginal hysterectomy if patients need one, but only 25% are done that way. See how vNOTES, an advanced approach, could offer more patients less invasive surgery.
PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.
